The Board has remanded the case due to a need for a new medical opinion regarding whether the Veteran's thyroid disorder, including thyroid cancer and Hashimoto's thyroiditis, is secondary to her service-connected hysterectomy.
The deciding factor: The Joint Motion found that the June 2016 VA addendum opinion did not comply with the Board’s April 2016 remand instructions because it did not consider both the Veteran's lay statements and medical evidence in rendering an opinion.
- Claimed conditions
- Thyroid disorder, Thyroid cancer, Hashimoto's thyroiditis
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- September 27, 2018
- Citation
- 18139389
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 18139389.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Dismissed
The Veteran's appeal for an initial rating in excess of 10 percent for tinnitus was dismissed. The Board granted service connection for hypothyroidism and Hashimoto's thyroiditis with complications, including depression, anxiety, insomnia, vitamin deficiencies, memory/cognitive impairment, unexplained arthralgias, fatigue, hair loss, and bradycardia.
- Whole decision: Granted
The Board has restored service connection for hypothyroidism, which was previously severed due to a finding of clear and unmistakable error (CUE) in the original grant. The evidence supports that the Veteran's hypothyroidism is related to his exposure to Agent Orange during military service.
- Whole decision: Dismissed
The Veteran's claim for service connection for Hashimoto's thyroiditis, to include hypothyroidism (claimed as Hashimoto's disease and thyroid condition) was granted in a June 2025 rating decision. The appeal is dismissed as moot since the issue has been resolved.
- Whole decision: Granted
The Veteran's claim for an earlier effective date (EED) for service connection of thyroid cancer is granted, with the EED set at September 13, 2018.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.